Oriven (Venlafaxine)

Venlafaxine acts on neurotransmitter pathways that influence mood and anxiety. It is indicated for several psychiatric conditions:

• Major Depressive Disorder: alleviates depressive symptoms and improves functional outcomes.
• Generalized Anxiety Disorder: reduces excessive worry and associated physical symptoms.
• Social Anxiety Disorder: helps decrease fear of social situations and improves social functioning.
• Panic Disorder: lessens the frequency and intensity of panic attacks.
• Fibromyalgia (off‑label in some regions): may reduce pain and fatigue associated with the condition.

• Venlafaxine inhibits the reuptake of serotonin and norepinephrine, increasing their concentrations in the synaptic cleft. At higher doses it also modestly blocks dopamine reuptake. This combined neurotransmitter enhancement normalizes mood regulation pathways in the central nervous system.

Venlafaxine may cause a range of adverse reactions. Patients should be aware of both frequent and less common events.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Headache: tension‑type or throbbing pain.
• Dry mouth: reduced salivation.
• Insomnia: difficulty falling or staying asleep.
• Sweating: increased perspiration, especially at night.
• Dizziness: light‑headed sensation, often positional.

Serious or Rare Side Effects

• Hypertensive crisis: sudden, severe rise in blood pressure.
• Serotonin syndrome: agitation, hyperthermia, muscle rigidity.
• Suicidal thoughts: emergence of new or worsening ideation.
• Severe liver injury: jaundice, elevated enzymes.
• Cardiac arrhythmias: irregular heart rhythm.
• Allergic reaction: rash, swelling, anaphylaxis.

Before starting Venlafaxine, clinicians should evaluate several safety factors:

• Cardiovascular assessment: monitor blood pressure and heart rate regularly.
• Psychiatric monitoring: watch for worsening depression or emergence of suicidal thoughts.
• Drug discontinuation: taper gradually to avoid discontinuation syndrome.
• Pregnancy and lactation: weigh potential benefits against risks; discuss with obstetrician.
• Liver and kidney function: adjust if significant impairment is present.

Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Venlafaxine can interact with a variety of medicines, altering efficacy or safety. Awareness of key interactions helps prevent adverse events.

Major Interactions (Avoid)

• MAO inhibitors: risk of serotonin syndrome; a 14‑day washout is required.
• Triplet antihypertensives (e.g., clonidine): may cause severe hypertension.
• Serotonergic opioids (e.g., tramadol): increase serotonin toxicity risk.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): raise venlafaxine levels.
• NSAIDs or anticoagulants: heightened bleeding tendency.
• Anticholinergic agents: additive dry‑mouth and constipation effects.